National Institutes of Health to Grant Exclusive License for Adeno-Associated Virus Promoter

Summary

The National Institutes of Health is considering granting an exclusive worldwide license to practice certain patents related to an Adeno-Associated Virus with an inverted terminal repeat sequence as a promoter, for use in treating and preventing human and animal diseases.